News

September 19, 2014 — ACR 2015, the all-new annual meeting of the American College of Radiology (ACR), will offer a variety of engaging and interactive clinical education sessions that focus on hot-button topics such as lung cancer screening, breast tomosynthesis and the latest in radiation therapy. Open to ACR members and non-members, ACR 2015 will be held May 17-21, 2015, at the Marriott Wardman Park Hotel in Washington, D.C.

Time September 19, 2014
Home
News

September 19, 2014 — Five presentations from the 2014 Breast Cancer Symposium in San Francisco earlier this month focused on new studies exploring preventive mastectomy, compliance with recommended screening mammography and risk of recurrence after pre-surgery therapy for breast cancer.

Time September 19, 2014
Home
News

Fovia Medical Inc. and Voyager Imaging, a Australia-based international provider of radiology products for more than 20 years, have collaborated to make natively integrated High Definition Volume Rendering (HDVR) available throughout Voyager PACS (picture archive and communication system) products.

Time September 18, 2014
Home
Technology

Ikonopedia showcased its new MQSA management system along with four new breast imaging reporting modules at the Intensive Breast Ultrasound Meeting, Sept. 11-14, 2014.

Time September 18, 2014
Home
Technology

The fifth edition of the American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS) Atlas is now available in a convenient electronic format.

Time September 18, 2014
Home
Technology

September 17, 2014 — The industry’s first ultrasound real-time 3-D volume enhancement product from ContextVision has been paired with brand new image visualization capabilities. The resulting product, REALiCE, will deliver photo-realistic and improved diagnostic-quality 3-D ultrasound images.

Time September 17, 2014
Home
Technology

September 17, 2014 — ViewRay announced the world’s first on-table adaptive radiation treatment program using the MRIdian system began at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. The MRIdian system provides a patented combination of continuous magnetic resonance imaging (MRI) and simultaneous radiation therapy delivery for the treatment of cancer.

Time September 17, 2014
Home
News

September 17, 2014 — Five-year-old Ashya King, the brain tumor patient whose case made headlines in Europe after his parents unlawfully took him from his hospital in Southampton, England, against the advice of doctors, began undergoing his prescribed treatment plan for proton therapy this week.

Time September 17, 2014
Home
News

At the 2014 annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 14-17 at San Francisco’s Moscone Center, Siemens Healthcare demonstrated how it innovates to advance the practice of radiation therapy (RT) for the benefit of patients by providing systems and solutions that enable optimal imaging, which can support radiation therapy (RT) treatment and follow-up.

Time September 17, 2014
Home
News

IBA and Philips Healthcare announced the signing of a global collaboration to provide advanced diagnostic and therapeutic solutions for the treatment of cancer.

Time September 17, 2014
Home
News

Cianna Medical Inc. announced five-year results for the first 200 hundred patients treated with the SAVI breast brachytherapy applicator, including excellent local control, low rates of toxicities and excellent cosmetic results.

Time September 17, 2014
Home
Technology

September 16, 2014 — CivaTech Oncology announced it has received U.S. Food and Drug Administration (FDA) clearance on its bioabsorbable planar radiation device. The implantable CivaSheet low-dose-rate (LDR) Palladium source is the only membrane-like brachytherapy device that is truly customizable to a specific patient’s condition and offers a unidirectional option to shield healthy tissue.

Time September 16, 2014
Home
News

September 16, 2014 — Advanced Accelerator Applications (AAA), an international specialist in molecular nuclear medicine, announced this week it has entered into an agreement with GE Healthcare in Italy to acquire its Italian FDG-PET imaging agent business (fluorodeoxyglucose positron emission tomography). This acquisition includes the license to market GE Healthcare’s SteriPET (FDG) imaging agent in Italy.

Time September 16, 2014
Home
News

September 16, 2014 — A large, international analysis of patients with stage IV non-small cell lung cancer (NSCLC) indicates that a patient’s overall survival (OS) rate can be related to factors including the timing of when metastases develop and lymph node involvement, and that aggressive treatment for “low-risk” patients leads to a five-year OS rate of 47.8 percent. The research was presented today at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO).

Time September 16, 2014
Home
Feature

Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy (SBRT) have a five-year survival rate of 40 percent, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

Time September 16, 2014
Home
Feature

A prospective clinical study that compared patient-reported outcomes of a broad set of cancer patients with bone metastases demonstrates that single fraction radiation therapy (SFRT) is equally as effective as multiple fraction radiation therapy (MFRT) when pain, function and quality of life are considered, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

Time September 16, 2014
Home
Feature

Mobility is equally preserved in cancer patients suffering from malignant spinal cord compression (MSCC) who receive a single dose of 10 Gy of radiation therapy (RT), compared to patients who receive five daily doses of 4 Gy of RT each, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

Time September 16, 2014
Home
Feature

Prostate cancer patients who received hypofractionated (HPFX) radiation therapy (RT) reported that their quality of life, as well as bladder and bowel function, were at similar levels before and after RT, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

Time September 15, 2014
Home
News

September 15, 2014 — A comparison of five-year sexual function outcomes, as reported by patients treated with external beam radiation therapy (EBRT) versus combination EBRT plus brachytherapy, indicates the utilization of vessel-sparing radiation therapy makes cure possible without compromising long-term sexual function, according to research presented today at ASTRO 2014.

Time September 15, 2014
Home
News

September 15, 2014 — The American Society for Radiation Oncology (ASTRO) released its second list of five radiation oncology-specific treatments that are commonly ordered but may not always be appropriate, as part of the national Choosing Wisely campaign, an initiative of the ABIM Foundation.

Time September 15, 2014
Home
Subscribe Now